AKT1 and type 2 diabetes mellitus: These data suggest that either insulin‐stimulated Akt phosphorylation or AMPK activation by RH‐XOS treatment leads to increase in GLUT4 translocation and enhanced glucose transport into skeletal muscle, which lessens hyperglycemia in T2DM rats.